All Cosmos Bio-Tech Holding Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 548.7 million compared to TWD 475.3 million a year ago. Revenue was TWD 548.7 million compared to TWD 475.3 million a year ago. Net income was TWD 48.88 million compared to TWD 34.53 million a year ago. Basic earnings per share from continuing operations was TWD 0.76 compared to TWD 0.54 a year ago. Diluted earnings per share from continuing operations was TWD 0.76 compared to TWD 0.54 a year ago.
For the nine months, sales was TWD 1,524.07 million compared to TWD 1,087.02 million a year ago. Revenue was TWD 1,524.07 million compared to TWD 1,087.02 million a year ago. Net income was TWD 118.17 million compared to TWD 46.93 million a year ago. Basic earnings per share from continuing operations was TWD 1.85 compared to TWD 0.73 a year ago. Diluted earnings per share from continuing operations was TWD 1.84 compared to TWD 0.73 a year ago.